You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
Moodys
Merck
Dow

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Silver nitrate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Silver nitrate?

Silver nitrate is an investigational drug.

There have been 20 clinical trials for Silver nitrate. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2019.

The most common disease conditions in clinical trials are Granuloma, Pleural Effusion, Malignant, and Pleural Effusion. The leading clinical trial sponsors are Assiut University, The University of Hong Kong, and University of Saskatchewan.

There are seventy-nine US patents protecting this investigational drug and five hundred and ninety-three international patents.

Recent Clinical Trials for Silver nitrate
TitleSponsorPhase
Phenol and Silver Nitrate Application in Pilonidal SinusUmraniye Education and Research HospitalPhase 4
Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital WartsAssiut UniversityPhase 3
A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in ChildrenDalhousie UniversityPhase 4

See all Silver nitrate clinical trials

Clinical Trial Summary for Silver nitrate

Top disease conditions for Silver nitrate
Top clinical trial sponsors for Silver nitrate

See all Silver nitrate clinical trials

US Patents for Silver nitrate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent, polymerizable compound and a fluorine atom-containing compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent and polymerizable compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent and polymerizable compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
Moodys
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.